Table 2. Characteristics of second angiography.
| Control (N = 115) | re-PCI (N = 88) | p value | |
|---|---|---|---|
| Age, y | 41.3 ± 4.5(y) | 43.1 ± 4.4(y) | 0.007 |
| Interval time, d | 513.0 ± 349.8 | 844.6 ± 567.0 | 0.000 |
| BMI, kg/m2 | 27.1 ± 3.3 | 27.4 ± 4.4 | 0.646 |
| SBP, mmHg | 128.8 ± 15.1 | 125.4 ± 15.6 | 0.116 |
| DBP, mmHg | 78.7 ± 11.4 | 77.4 ± 11.5 | 0.1 |
| HR, b/m | 75.1 ± 11.7 | 74.6 ± 11.9 | 0.788 |
| Hypertension, n (%) | 62 | 52 | 0.461 |
| DM, n (%) | 30 | 31 | 0.461 |
| Current smoker, n (%) | 81 | 61 | 0.789 |
| Previous MI, n (%) | 52 | 39 | 0.898 |
| Glucose, mmol/l | 6.35 ± 2.87 | 7.33 ± 3.31 | 0.025 |
| HbA1C, mmol/l | 6.50 ± 0.98 | 6.71 ± 1.25 | 0.204 |
| Total cholesterol, mmol/l | 3.50 ± 0.83 | 3.52 ± 1.08 | 0.85 |
| Triglycerides, mmol/l | 1.58 ± 0.82 | 1.71 ± 0.755 | 0.263 |
| LDL, mmol/l | 2.08 ± 0.71 | 2.09 ± 0.91 | 0.951 |
| HDL, mmol/l | 0.92 ± 0.21 | 0.89 ± 0.23 | 0.366 |
| CKMB, ng/ml | 4.2 ± 5.1 | 5.8 ± 13.6 | 0.228 |
| Troponin T, ng/l | 0.01 ± 0.04 | 0.09 ± 0.29 | 0.004 |
| Presentation, n (%) | |||
| NSTEMI | 2 | 5 | 0.255 |
| STEMI | 0 | 4 | – |
| Stent length, mm | – | 23.0 ± 7.1 | – |
| Stent diameter, mm | – | 3.02 ± 0.46 | – |
| Aspirin | 112 | 88 | – |
| Clopidogrel | 107 | 79 | 0.405 |
| Ticagrelor | 16 | 18 | 0.216 |
| DAPT | 112 | 88 | – |
| Statin | 112 | 86 | 0.761 |
Note:
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; DM, diabetes mellitus; TC, total cholesterol; TG, Triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; STEMI, ST-elevated myocardial infarction; NSTEMI, non-ST elevated myocardial infarction; LM, left main artery; LAD, left anterior descending branch; LCX, left circumflex artery; RA, right artery; DAPT, dual antiplatelet therapy.